SII manufactures and ships ebola vaccine to Uganda EP News Bureau Dec 16, 2022 The bivalent vaccine is designed to target both major strains of ebola virus
British scientists behind key COVID trial launch study to test monkeypox treatment Reuters Aug 24, 2022 Although there are vaccines developed for the closely related smallpox that can reduce the risk of catching monkeypox, there are…
AstraZeneca says its COVID shot has market potential despite lower demand Reuters May 2, 2022 AstraZeneca has started earning a modest profit on the vaccine, which was initially sold at-cost. However, the British drugmaker…
US scientists develop Nipah virus vaccine that can save lives in just three days IANS Mar 17, 2022 The results, published in the journal Proceedings of the National Academy of Sciences (PNAS), showed all vaccinated monkeys were…
GSK and Oxford University announce Oxford-GSK Institute of Molecular and Computational Medicine EP News Bureau Dec 3, 2021 The institute aims to improve the success and speed of research and development of new medicines, building on insights from human…
ICMR proposes clinical trial along with Oxford University to evaluate COVID-19 therapy Press Trust of India Jul 9, 2021 The trial -- 'India-UK RECOVERY (Randomised Evaluation of COVID-19 therapy)'-- will be a multi-centre, adaptive platform trial on…
Biotech start-up Vaccitech files for US IPO Lakshmipriya Nair Apr 10, 2021 Vaccitech owns the technology behind the COVID-19 vaccine developed by Oxford University and AstraZeneca
AstraZeneca says COVID-19 vaccine 76 per cent effective in new analysis, to seek US approval Reuters Mar 25, 2021 AstraZeneca said its COVID-19 vaccine was 76 per cent effective in a new analysis of its US trial - only a tad lower than the…
Oxford AstraZeneca jabs effective against severe COVID new trial in US confirms Press Trust of India Mar 23, 2021 A large trial in the US and two South American countries of the Oxford-AstraZeneca vaccine has shown 79 per cent efficacy rate at…
No evidence of greater blood clot risk from vaccine: AstraZeneca Reuters Mar 15, 2021 Its review covered more than 17 million people vaccinated in the UK and EU and comes after health authorities in some countries…